Pirzad Jahromi G, Shabanzadeh A, Mokhtari Hashtjini M, Sadr S, Vani J, Raouf Sarshoori J
Iran J Basic Med Sci. 2018; 21(10):1004-1012.
PMID: 30524673
PMC: 6281073.
DOI: 10.22038/IJBMS.2018.29382.7100.
Shabanzadeh A, DOnofrio P, Monnier P, Koeberle P
Cell Death Dis. 2015; 6:e1967.
PMID: 26539914
PMC: 4670918.
DOI: 10.1038/cddis.2015.272.
Lichtman J, Naert L, Allen N, Watanabe E, Jones S, Barry L
Circ Cardiovasc Qual Outcomes. 2010; 4(1):30-8.
PMID: 21098780
PMC: 3073519.
DOI: 10.1161/CIRCOUTCOMES.109.850883.
Cheng E, Cohen S, Lee M, Vassar S, Chen A
Am J Prev Med. 2010; 38(1):47-53.
PMID: 20117556
PMC: 2818982.
DOI: 10.1016/j.amepre.2009.08.029.
Hohmann C, Klotz J, Radziwill R, Jacobs A, Kissel T
Pharm World Sci. 2009; 31(5):550-558.
PMID: 19633917
DOI: 10.1007/s11096-009-9315-y.
Secondary prevention of atherothrombotic events after ischemic stroke.
Adams Jr H
Mayo Clin Proc. 2009; 84(1):43-51.
PMID: 19121254
PMC: 2664570.
DOI: 10.4065/84.1.43.
Current strategies for ischemic stroke prevention: role of multimodal combination therapies.
Alberts M, Ovbiagele B
J Neurol. 2007; 254(10):1414-26.
PMID: 17934879
DOI: 10.1007/s00415-007-0569-9.
Use of 3-D magnetic resonance electrical impedance tomography in detecting human cerebral stroke: a simulation study.
Gao N, Zhu S, He B
J Zhejiang Univ Sci B. 2005; 6(5):438-45.
PMID: 15822161
PMC: 1389764.
DOI: 10.1631/jzus.2005.B0438.
Secondary stroke prevention: review of clinical trials.
Elkind M
Clin Cardiol. 2004; 27(5 Suppl 2):II25-35.
PMID: 15188933
PMC: 6654407.
DOI: 10.1002/clc.4960271405.
Need for Continued Use of Anticoagulants After Intracerebral Hemorrhage.
Estol C, Kase C
Curr Treat Options Cardiovasc Med. 2003; 5(3):201-209.
PMID: 12777198
DOI: 10.1007/s11936-003-0004-1.
Cardiovascular drug therapy in the elderly: theoretical and practical considerations.
Williams B, Kim J
Drugs Aging. 2003; 20(6):445-63.
PMID: 12710864
DOI: 10.2165/00002512-200320060-00004.
Antithrombotic drug treatment of pediatric patients with ischemic stroke.
Nowak-Gottl U, Straeter R, Sebire G, Kirkham F
Paediatr Drugs. 2003; 5(3):167-75.
PMID: 12608881
DOI: 10.2165/00128072-200305030-00003.
Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).
Cuadrado M
Curr Rheumatol Rep. 2002; 4(5):392-8.
PMID: 12217243
DOI: 10.1007/s11926-002-0083-0.
Choices in medical management for prevention of acute ischemic stroke.
Fleck J, Biller J
Curr Neurol Neurosci Rep. 2002; 1(1):33-8.
PMID: 11898498
DOI: 10.1007/s11910-001-0075-x.
How well is the clinical importance of study results reported? An assessment of randomized controlled trials.
Chan K, Molnar F, Laupacis A
CMAJ. 2001; 165(9):1197-202.
PMID: 11706908
PMC: 81581.
Antiplatelet therapy in secondary stroke prevention.
Worrall B, JOHNSTON K
Curr Atheroscler Rep. 2000; 2(2):104-9.
PMID: 11122732
DOI: 10.1007/s11883-000-0103-3.
Acute Ischemic Stroke.
Chan , Albers
Curr Treat Options Neurol. 2000; 1(2):83-96.
PMID: 11096699
DOI: 10.1007/s11940-999-0009-5.
Clopidogrel: a review of its use in the prevention of atherothrombosis.
Jarvis B, Simpson K
Drugs. 2000; 60(2):347-77.
PMID: 10983738
DOI: 10.2165/00003495-200060020-00012.
Use of oral anticoagulants in older patients.
Sebastian J, Tresch D
Drugs Aging. 2000; 16(6):409-35.
PMID: 10939307
DOI: 10.2165/00002512-200016060-00003.
